Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
ORLANDO, Fla., May 17, 2005 -- OSI Pharmaceuticals (Nasdaq: OSIP) First-Line, Monotherapy Non-Small Cell Lung Cancer Data Presented Symptom Response / Quality of Life Analysis from the...
ORLANDO, Fla., May 16, 2005 -- OSI Pharmaceuticals (Nasdaq:OSIP) provided an informational update summarizing highlights from presentations on the analysis of EGFR mutation and gene amplification...
Data Presented at Plenary Session at Annual ASCO Meeting ORLANDO, Fla., May 14, 2005 /PRNewswire-FirstCall via COMTEX/ -- Genentech, Inc. (NYSE: DNA) and OSI Pharmaceuticals (Nasdaq: OSIP) today...
MELVILLE, N.Y. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 2, 2005--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc. (NYSE: DNA) announced today that OSI submitted a...
New Entity Ranks Astellas Among Top 20 Worldwide Pharmaceutical Companies Deerfield, Ill., April 1, 2005—Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. officially...
Follow U.S. news
